domingo, 3 de julio de 2022

Most therapeutic antibodies for treating COVID-19 patients do not inhibit emerging Omicron subvariants

Most therapeutic antibodies for treating COVID-19 patients do not inhibit emerging Omicron subvariants

No hay comentarios:

Publicar un comentario